Evaluation of methotrexate and corticosteroids for the treatment of localized scleroderma (morphoea) in children.
Br J Dermatol
1013 - 1020.
Localized scleroderma (LS) or morphoea is often considered to be a benign self-limiting condition confined to the skin and subcutaneous tissue. However, the course of the disease is unpredictable and severe functional and cosmetic disability may result. Drug treatment with systemic corticosteroids in combination with methotrexate has been reported to be beneficial in LS, but data in children is limited.
|Title:||Evaluation of methotrexate and corticosteroids for the treatment of localized scleroderma (morphoea) in children.|
|Keywords:||Adolescent, Child, Child, Preschool, Dermatologic Agents, Disease Progression, Drug Evaluation, Drug Therapy, Combination, Female, Follow-Up Studies, Glucocorticoids, Humans, Male, Methotrexate, Prednisolone, Recurrence, Retrospective Studies, Scleroderma, Localized, Thermography, Treatment Outcome|
|UCL classification:||UCL > School of Life and Medical Sciences > Faculty of Medical Sciences > Infection and Immunity (Division of)
UCL > School of Life and Medical Sciences > Faculty of Medical Sciences > Medicine (Division of)
Archive Staff Only